Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study
Authors:
Open Access
- 18 November 2003
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (11) , 1071-1075
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndromeBlood, 2002
- Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortalityTransplantation and Cellular Therapy, 2002
- Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemiaAmerican Journal of Hematology, 2001
- Hematopoietic stem cell transplantation in patients with myelodysplastic syndromeLeukemia Research, 2000
- Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT surveyBone Marrow Transplantation, 1998
- Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcomeBone Marrow Transplantation, 1998
- Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumorsCancer, 1997
- Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.Journal of Clinical Oncology, 1996
- Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.Journal of Clinical Oncology, 1996
- Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factorsBlood, 1996